By: Kairos Ventures On: May 9, 2022 In: MemVerge, Portfolio News

is the first to be recognized as a double Bio-IT World Award winner. It was recognized as the Bio-IT...

Read more
By: Kairos Ventures On: May 3, 2022 In: Foldax, Portfolio News

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial...

Read more

Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...

Read more
By: Kairos Ventures On: April 28, 2022 In: Amorphology, Portfolio News

Amorphology has partnered with AddiTec to develop the additive manufacturing of multi-metal gear components for robotics.

Read more

Chimera Bioengineering is having a big week. The San Francisco-based biotherapeutics company announced Thursday that it has won the Asian Fund for...

Read more
By: Kairos Ventures On: April 28, 2022 In: Delpor, Portfolio News

Delpor announced that it has initiated and dosed the first subjects in a phase 1 clinical trial of DLP-160,...

Read more
By: Kairos Ventures On: April 27, 2022 In: Amorphology, Portfolio News

Amorphology, a NASA spinoff company, is a leader in the application of advanced materials and manufacturing technologies for the...

Read more
By: Kairos Ventures On: April 11, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced that the laboratory of Gary Schwartz, MD at Columbia University Irving Medical Center presented new findings...

Read more
By: Charissa On: April 6, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced it has been awarded a Phase 2 Bridge Small Business Innovation Research ("SBIR") Award by the...

Read more

Axial Therapeutics announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be...

Read more